Your browser doesn't support javascript.
loading
Commentary on "Low Molecular Weight Heparin is Superior to Aspirin in the Prevention of Thromboembolic Disease, or is It? Response to an Editorial".
Parvizi, Javad; DeMik, David E; Hozack, William J; Dunbar, Michael J; Mont, Michael A; Lachiewicz, Paul A.
Affiliation
  • Parvizi J; Rothman Orthopaedic Institute Philadelphia, Philadelphia, Pennsylvania.
  • DeMik DE; Rothman Orthopaedic Institute Philadelphia, Philadelphia, Pennsylvania.
  • Hozack WJ; Rothman Orthopaedic Institute Philadelphia, Philadelphia, Pennsylvania.
  • Dunbar MJ; Dalhousie University Halifax, Halifax, Nova Scotia, Canada.
  • Mont MA; Rubin Institute for Advanced Orthopedics Sinai Hospital of Baltimore, Baltimore, Maryland.
  • Lachiewicz PA; Duke University Durham, Durham, North Carolina.
J Arthroplasty ; 38(4): e9, 2023 04.
Article in En | MEDLINE | ID: mdl-36906351
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thromboembolism / Heparin, Low-Molecular-Weight Aspects: Patient_preference Limits: Humans Language: En Journal: J Arthroplasty Journal subject: ORTOPEDIA Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thromboembolism / Heparin, Low-Molecular-Weight Aspects: Patient_preference Limits: Humans Language: En Journal: J Arthroplasty Journal subject: ORTOPEDIA Year: 2023 Document type: Article